Related Experiment Video
Updated: Aug 13, 2026
11:14
Ex Vivo Infection of Human Lymphoid Tissue and Female Genital Mucosa with Human Immunodeficiency Virus 1 and Histoculture
Published on: October 12, 2018
Cellular latency of human immunodeficiency virus type 1
R J Pomerantz1, O Bagasra, D Baltimore
1Jefferson Medical College, Department of Medicine, Thomas Jefferson University, Philadelphia, Philadelphia 19107.
Current Opinion in Immunology
|August 1, 1992
Summary
Understanding human immunodeficiency virus type 1 (HIV-1) latency is key to developing new treatments. Research into the molecular mechanisms of HIV-1 cellular latency offers insights into the prolonged asymptomatic period of infection.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human immunodeficiency virus type 1 (HIV-1) infection features a lengthy clinical latency phase.
- This asymptomatic period is partly due to cellular mechanisms establishing HIV-1 latency.
- Understanding these mechanisms is crucial for managing HIV-1 infection.
Purpose of the Study:
- To explore the molecular mechanisms underlying cellular latency of HIV-1.
- To elucidate the role of cellular latency in the prolonged asymptomatic period of HIV-1 infection.
- To inform the development of novel therapeutic strategies against HIV-1.
Main Methods:
- Review of recent advances in understanding HIV-1 cellular latency.
- Analysis of molecular mechanisms governing viral latency in vivo.
- Exploration of cellular retroviral latency models.
Main Results:
- Recent research has advanced the understanding of molecular mechanisms in HIV-1 cellular latency.
- These mechanisms contribute to the variable duration of asymptomatic HIV-1 infection.
- Insights into in vivo cellular latency are emerging.
Conclusions:
- Elucidating the molecular basis of HIV-1 cellular latency is critical.
- Understanding viral latency in vivo is essential for designing effective HIV-1 therapies.
- Further research into cellular latency mechanisms will guide future treatment strategies.
Related Concept Videos
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:28Herpes
Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
01:27Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...